瞄准: 在 ischemia/reperfusion 损害(IRI ) 以后在老鼠大脑在神经发生上调查人参皂甙 Rd (Rd ) 的效果。
Aim: To investigate the effects of ginsenoside Rd (Rd) on neurogenesis in rat brain after ischemia/reperfusion injury (IRI). Methods: Male SD rats were subjected to transient middle cerebral artery occlusion (MCAO) followed by reperfusion. The rats were injected with Rd (1, 2.5, and 5 mg·kg^-1·d^-1, ip) from d I to d 3 after MCAO, and with BrdU (50 mg·kg^-1·d^-1, ip) from d 3 to d 6, then sacrificed on 7 d. The infarct size and neurological scores were assessed. Neurogenesis in the brains was detected by BrdU, DCX, Nestin, and GFAP immunohistochemistry staining. PC12 cells subjected to OGD/reperfusion were used as an in vitro model of brain ischemia. VEGF and BDNF levels were assessed with ELISA, and Akt and ERK phosphorylation was measured using Western blotting. Results: Rd administration dose-dependently decreased the infarct size and neurological scores in the rats with tRI. The high dose of Rd (5 mg.kg'l〈1-1) significantly increased Akt phosphorylation in ipsilateral hemisphere, and markedly increased the number of BrdU/ DCX and Nestin/GFAP double-positive cells in ischemic area, which was partially blocked by co-administration of the PI3 kinase inhibi- tor LY294002. Treatment with Rd (25, 50, and 100 pmol/L) during reperfusion significantly increased the expression of VEGF and BDNF in PC12 cells with IRI. Furthermore, treatment with Rd dose-dependently increased the phosphorylation of Akt and ERK, and significantly decreased PC12 cell apoptosis, which were blocked by co-application of LY294002. Conclusion: Rd not only attenuates ischemia/reperfusion injury in rat brain, but also promotes neurogenesis via increasing VEGF and BDNF expression and activating the PI3K/Akt and ERK1/2 pathways.